SCHEMBL13746544

SCHEMBL13746544

CC(C)(C)OC(=O)N1C2CC2C[C@H]1c1nc2c([nH]1)-c1ccc(Br)cc1CC2

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TYMS P04818 2/20 0.35
CDK1 P06493 2/20 0.34
SRD5A1 P18405 1/20 0.31
SRD5A2 P31213 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRA6 Q16445 1/20 0.31
USP30 Q70CQ3 2/20 0.30
ABHD6 Q9BV23 1/20 0.30
GPR119 Q8TDV5 1/20 0.30
CCNB2 O95067 1/20 0.30
CCNB1 P14635 1/20 0.30
GSK3B P49841 1/20 0.30
CCNB3 Q8WWL7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2065597 1.00 TYMS (0.35) TYMSCDK1SRD5A1SRD5A2GABRA1
SCHEMBL883262 1.00 TYMS (0.35) TYMSCDK1SRD5A1SRD5A2GABRA1
SCHEMBL2065596 1.00 TYMS (0.35) TYMSCDK1SRD5A1SRD5A2GABRA1
SCHEMBL12328158 0.91 GPR119 (0.31) GPR119
SCHEMBL16440338 0.88 SPR (0.33) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL21334117 0.88 SPR (0.33) CDK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL10234322 0.87 GABRG2 (0.33) TYMSGABRA1GABRG2GABRB3GABRA5
SCHEMBL12295804 0.87 GABRG2 (0.33) TYMSGABRA1GABRG2GABRB3GABRA5
SCHEMBL2066099 0.86 TYMS (0.39) TYMSSRD5A1SRD5A2
SCHEMBL12295799 0.85 GABRA5 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009102633-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 WO disclosed